Lennart Eriksson

Publications
Public outreach and news

Articles

Article: NURSING RESEARCH. 2015;64(4):264-271

Attitudes of Nurses and Physicians About Clinical Autopsy in Neonatal and Adult Hospital Care: A Survey in Sweden.

Mjörnheim B; Rosendahl A; Eriksson LC; Takman C
Article: JOURNAL OF SURGICAL RESEARCH. 2013;184(2):847-854

Sorafenib prolongs liver regeneration after hepatic resection in rats.

Mollbrink A; Augsten M; Hultcrantz R; Eriksson LC; Stål P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2012;425(2):348-352

The anti-carcinogenic effect of statins in a rat model correlates with levels and synthesis of ubiquinone.

Acimovic J; Lövgren-Sandblom A; Eriksson LC; Björkhem-Bergman L
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2012;47(5):591-600

Iron-regulatory gene expression during liver regeneration.

Mollbrink A; Holmström P; Sjöström M; Hultcrantz R; Eriksson LC; Stål P
Article: HEPATOLOGY. 2012;55(4):1112-1121

Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.

Rohr-Udilova N; Sieghart W; Eferl R; Stoiber D; Björkhem-Bergman L; Eriksson LC; Stolze K; Hayden H; Keppler B; Sagmeister S; Grasl-Kraupp B; Schulte-Hermann R; Peck-Radosavljevic M
Article: BIOCHEMICAL PHARMACOLOGY. 2012;83(5):687-693

The effect of sodium selenite on liver growth and thioredoxin reductase expression in regenerative and neoplastic liver cell proliferation.

Erkhembayar S; Mollbrink A; Eriksson LC
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2012;417(3):1046-1051

Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development.

Skogastierna C; Johansson M; Parini P; Eriksson M; Eriksson LC; Ekström L; Björkhem-Bergman L
Article: JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 2011;25(4):254-259

Selenium homeostasis and induction of thioredoxin reductase during long term selenite supplementation in the rat.

Erkhembayar S; Mollbrink A; Eriksson M; Larsen EH; Eriksson LC
Article: ANTICANCER RESEARCH. 2010;30(4):1105-1112

Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation.

Björkhem-Bergman L; Acimovic J; Torndal U-B; Parini P; Eriksson LC
Article: CANCER LETTERS. 2009;282(1):116-123

Selenite is a potent cytotoxic agent for human primary AML cells.

Olm E; Jönsson-Videsäter K; Ribera-Cortada I; Fernandes AP; Eriksson LC; Lehmann S; Rundlöf A-K; Paul C; Björnstedt M
Article: LIVER INTERNATIONAL. 2006;26(8):976-985

Expression of iron regulatory genes in a rat model of hepatocellular carcinoma.

Holmström P; Gåfvels M; Eriksson LC; Dzikaite V; Hultcrantz R; Eggertsen G; Stål P
Article: TRANSPLANT INTERNATIONAL. 2005;18(8):992-1000

Adriamycin cytotoxicity may stimulate growth of hepatocellular tumours in an experimental model for adjuvant systemic chemotherapy in liver transplantation.

Rissler P; Söderdahl G; Nordman T; Xia L; Torndal U-B; Björnstedt M; Ericzon B-G; Olsson JM; Eriksson LC
Article: BIOCHEMICAL PHARMACOLOGY. 2005;69(12):1765-1772

The role of thioredoxin reductase activity in selenium-induced cytotoxicity.

Madeja Z; Sroka J; Nyström C; Björkhem-Bergman L; Nordman T; Damdimopoulos A; Nalvarte I; Eriksson LC; Spyrou G; Olsson JM; Björnstedt M
Article: HISTOCHEMISTRY AND CELL BIOLOGY. 2005;123(4-5):441-446

Human sterol 12a-hydroxylase (CYP8B1) is mainly expressed in hepatocytes in a homogenous pattern.

Wang J; Greene S; Eriksson LC; Rozell B; Reihnér E; Einarsson C; Eggertsen G; Gåfvels M
Article: CARCINOGENESIS. 2005;26(1):125-131

Selenium prevents tumor development in a rat model for chemical carcinogenesis.

Björkhem-Bergman L; Torndal U-B; Eken S; Nyström C; Capitanio A; Larsen EH; Björnstedt M; Eriksson LC
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2004;279(52):54510-54517

Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation.

Nalvarte I; Damdimopoulos AE; Nystöm C; Nordman T; Miranda-Vizuete A; Olsson JM; Eriksson L; Björnstedt M; Arnér ESJ; Spyrou G
Article: BIOCHEMICAL PHARMACOLOGY. 2004;67(3):513-522

Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system.

Jönsson-Videsäter K; Björkhem-Bergman L; Hossain A; Söderberg A; Eriksson LC; Paul C; Rosén A; Björnstedt M
Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(2):131-138

Differentially expressed transcripts in neoplastic hepatic nodules and neonatal rat liver studied by cDNA microarray analysis.

Tellgren A; Wood TJJ; Flores-Morales A; Torndal U-B; Eriksson L; Norstedt G
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2003;278(4):2141-2146

The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress.

Xia L; Nordman T; Olsson JM; Damdimopoulos A; Björkhem-Bergman L; Nalvarte I; Eriksson LC; Arnér ESJ; Spyrou G; Björnstedt M
Article: BIOCHEMICAL PHARMACOLOGY. 2002;63(10):1875-1884

Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity. Effects on thioredoxin reductase and glutathione reductase.

Björkhem-Bergman L; Jönsson K; Eriksson LC; Olsson JM; Lehmann S; Paul C; Björnstedt M
Article: JOURNAL OF HEPATOLOGY. 2001;35(2):259-264

Increased levels of cytosolic thioredoxin reductase activity and mRNA in rat liver nodules.

Björkhem L; Teclebrhan H; Kesen E; Olsson JM; Eriksson LC; Björnstedt M
Article: FEBS JOURNAL. 2001;268(5):1486-1490

Reduction of ubiquinone by lipoamide dehydrogenase. An antioxidant regenerating pathway.

Xia L; Björnstedt M; Nordman T; Eriksson LC; Olsson JM
Article: HEPATOLOGY. 2000;32(4 Pt 1):701-710

Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo.

Van Gijssel HE; Ohlson LC; Torndal UB; Mulder GJ; Eriksson LC; Porsch-Hällström I; Meerman JH
Article: TOXICOLOGY. 2000;144(1-3):51-56

Density-dependent growth of normal and nodular hepatocytes.

Bock KW; Gschaidmeier H; Bock-Hennig BS; Eriksson LC
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2000;35(1):83-89

Diet restriction increases ubiquinone contents and inhibits progression of hepatocellular carcinoma in the rat.

Wang GS; Olsson JM; Eriksson LC; Stål P
Article: LIVER. 1999;19(4):326-334

Effects of dietary iron overload on progression in chemical hepatocarcinogenesis.

Stål P; Wang GS; Olsson JM; Eriksson LC
Article: FEBS LETTERS. 1999;448(1):190-192

Ubiquinone is reduced by lipoamide dehydrogenase and this reaction is potently stimulated by zinc.

Olsson JM; Xia L; Eriksson LC; Björnstedt M
Article: JOURNAL OF HEPATOLOGY. 1999;30(4):689-698

Dietary iron overload inhibits carbon tetrachloride-induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation.

Wang GS; Eriksson LC; Xia L; Olsson J; Stål P
Article: CARCINOGENESIS. 1997;18(12):2447-2451

Inositol 1,4,5-trisphosphate turnover enzymes--activities and subcellular distribution in hepatocarcinogenesis.

Nilsson H; Torndal UB; Eriksson LC
Article: JOURNAL OF HEPATOLOGY. 1997;27(3):562-571

Studies on genotoxic effects of iron overload and alcohol in an animal model of hepatocarcinogenesis.

Stål P; Olsson J; Svoboda P; Hultcrantz R; Harms-Ringdahl M; Eriksson LC
Article: CARCINOGENESIS. 1997;18(4):649-655

Induced drug resistance inhibits selection of initiated cells and cancer development.

Rissler P; Torndal UB; Eriksson LC
Article: HEPATOLOGY. 1996;24(4):849-854

Role of the pituitary in tumor promotion with ethinyl estradiol in rat liver.

Hallstrom IP; Liao DZ; Assefaw-Redda Y; Ohlson LC; Sahlin L; Eneroth P; Eriksson LC; Gustafsson JA; Blanck A
Article: CARCINOGENESIS. 1995;16(9):2135-2141

Early formation of DNA adducts compared with tumor formation in a long-term tumor study in rats after administration of 2-nitrofluorene.

Cui XS; Torndal UB; Eriksson LC; Möller L
Article: CARCINOGENESIS. 1995;16(3):599-605

Enzymes of the mevalonate pathway in rat liver nodules induced by 2-acetylaminofluorene treatment.

Olsson JM; Schedin S; Teclebrhan H; Eriksson LC; Dallner G
Article: HEPATOLOGY. 1995;21(2):521-528

The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis.

Stál P; Hultcrantz R; Möller L; Eriksson LC
Show more

All other publications

Review: IN VIVO. 2012;26(4):527-535

Review: Exploring anticarcinogenic agents in a rat hepatocarcinogenesis model--focus on selenium and statins.

Björkhem-Bergman L; Ekström L; Eriksson LC
Meeting abstract: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2007;5(4):347

Selenite is a superior cytotoxic agent to human primary leukemia cells

Olm E; Jonsson-Videsaler K; Rundlof AK; Fernandes AP; Ribera I; Eriksson L; Paul C; Bjornstedt M
Published conference paper: BIOFACTORS. 2003;18(1-4):45-50

Regeneration of the antioxidant ubiquinol by lipoamide dehydrogenase, thioredoxin reductase and glutathione reductase.

Nordman T; Xia L; Björkhem-Bergman L; Damdimopoulos A; Nalvarte I; Arnér ESJ; Spyrou G; Eriksson LC; Björnstedt M; Olsson JM
Corrigendum: BIOCHEMICAL PHARMACOLOGY. 2002;64(1):159

Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity -: Effects on thioredoxin reductase and glutathione reductase (vol 63, pg 1875, 2002)

Björkhem-Bergman L; Jönsson K; Eriksson LC; Olsson JM; Lehmann S; Paul C; Björnstedt M
Published conference paper: CELLULAR ONCOLOGY. 2001;23(3-4):143-152

DNA ploidy and S-phase fraction in carcinoma of the gallbladder related to histopathology, number of gallstones and survival.

Gustafsson U; Einarsson C; Eriksson LC; Gadaleanu V; Sahlin S; Tribukait B
Published conference paper: CHEMICO-BIOLOGICAL INTERACTIONS. 2001;133(1-3):349-354

Alterations of glutathione levels and related enzyme activities in non-tumourous rat liver cells after long-term treatment with adriamycin and/or cyclosporine A

Carlson T; Björnstedt M; Rissler P; Bai L; Eriksson LC; Olsson JM
Meeting abstract: GASTROENTEROLOGY. 1998;114(4):A522

Gallstones and the development of gallbladder cancer.

Gustafsson U; Einarsson C; Eriksson L; Sahlin S; Tribukait B; Gadaleanu V
Published conference paper: MINERAL AND ELECTROLYTE METABOLISM. 1997;23(3-6):273-276

Serum ferritin and tissue iron in anemic dialysis patients.

Bárány P; Eriksson LC; Hultcrantz R; Pettersson E; Bergström J

Articles

All other publications

News from KI

Events from KI